Tag Archives: novartis
Xolair possibly linked to heart attack and stroke
The FDA warned on July 16 that asthma drug Xolair may be linked to increased risk of heart attacks and strokes. Xolair is sold in the U.S. by Novartis and Genentech, a division of Roche. An ongoing study has revealed … Continue reading
Posted in Defective Drugs, heart attacks, stroke
Tagged fda, genentech, heart-attack, novartis, stroke, warning, xolair